India has administered more than 80 lakh HPV vaccinations under a nationwide campaign.
The campaign was launched on February 28 for 14-year-old girls.
The single-dose Gardasil-4 vaccine is offered free at government health facilities.
Participation is voluntary and requires mandatory parental consent.
The Delhi High Court recently refused to stay the campaign while emphasizing safety procedures.
One report said several states have achieved complete coverage of their target populations.
A quick read on shared facts, changing details, and different emphasis.
The reporting broadly agrees that India has crossed the 80 lakh mark in HPV vaccinations and that the campaign targets adolescent girls with free, voluntary doses. It also agrees that parental consent and government facilities are central to how the programme is being run.
What may still change is the reported total as the campaign continues and more doses are added, and one account says some states have already reached complete coverage. The legal and procedural context may also evolve, as a court has recently declined to halt the programme while noting safety procedures.
Swipe through the perspectives. Labels describe coverage framing, not truth or quality.
The supportive coverage treats the milestone as a major step in cervical cancer prevention and preventive healthcare. It highlights that India has crossed 80 lakh HPV doses under a nationwide effort aimed at adolescent girls. The reports emphasize that the vaccine is free, voluntary, and given with parental consent at government facilities. One account frames the result as progress toward a healthier and cancer-free future.
This view focuses on India crosses 80 lac HPV vaccinations under nationwide campaign.
The latest eight dated reports, from earliest to newest.
jharkhandstatenews.com
Attributed summaries from official party channels. These are claims, not independent reporting or fact checks.
Scan each source take, then open the original article.
The Union health ministry announced that India has administered over 80 lakh human papillomavirus vaccinations under a nationwide campaign launched on February 28 for 14-year-old girls. The ministry stated that the single-dose Gardasil-4 vaccine is provided free at government health facilities with mandatory parental consent and voluntary participation. Additionally, the article noted that the Delhi High Court recently refused to stay the campaign while emphasizing safety procedures.
India surpassed 80 million doses of the HPV vaccine under the National HPV Vaccination Campaign launched in February 2026, according to the article. The campaign provides free voluntary single-dose vaccinations to 14-year-old girls with parental consent at government facilities. Several states achieved complete coverage of their target populations, while the initiative leverages the U-WIN digital platform for tracking.
India crossed the 80-lakh mark in HPV vaccinations under a nationwide effort to protect adolescent girls against cervical cancer, the Centre announced. The campaign provides free Gardasil-4 doses on a voluntary basis with parental consent across all states and union territories. The report also notes that the Supreme Court recently declined to entertain a public-interest petition challenging the programme.
India has officially crossed the milestone of 80 lakh Human Papillomavirus vaccinations. The Ministry of Health and Family Welfare reported that this achievement marks a major step in strengthening preventive healthcare and protecting citizens against HPV-associated cancers. Officials stated that every dose administered brings the nation closer to achieving a healthier and cancer-free future.
World Health Organization Director-General Tedros Adhanom congratulated India on reaching eight million HPV vaccine doses. Union Health Minister Jagat Prakash Nadda highlighted that the national campaign, launched in February 2026, provides free and voluntary single-dose vaccinations for fourteen-year-old girls with parental consent. Officials and international leaders praised the efforts of frontline health workers and state teams in driving the cervical cancer elimination initiative forward.
The article reports on the rising diagnosis of celiac disease among adults and elderly patients at the Post Graduate Institute of Medical Sciences in Rohtak. Doctors highlighted that the autoimmune disorder frequently presents with atypical symptoms beyond the digestive system, making diagnosis more challenging. The report details diagnostic patterns and stresses that lifelong avoidance of gluten is the only established treatment.